Latest filing published 14 Dec 2006 for Ligand Pharmaceuticals INC, €29k.
Insider track record
No signal scores available.
Andres Negro-Vilar: trading record in brief
Andres Negro-Vilar discloses dealings in Ligand Pharmaceuticals Inc to SEC (Form 4). In total, 12 filings cover trades dated from 11 December 2006 to 14 December 2006.
Every open-market trade on record is a sale: 6 sales worth €341k. Besides market trades, the filings include 6 option exercises.
The newest entry dates from 14 December 2006: an option exercise of €29k, in Ligand Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andres Negro-Vilar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$7.63Common StockSEC:0000886163-06-000150:0
- 5,000 shares@ US$10.87Common StockSEC:0000886163-06-000150:1
- 5,625 shares@ US$7.63Common StockSEC:0000886163-06-000150:2
- 5,625 shares@ US$11.19Common StockSEC:0000886163-06-000150:3
- 1,041 shares@ US$7.63Common StockSEC:0000886163-06-000150:4
- 1,041 shares@ US$11.19Common StockSEC:0000886163-06-000150:5
- 18,334 shares@ US$7.63Common StockSEC:0000886163-06-000143:0
- 18,334 shares@ US$10.76Common StockSEC:0000886163-06-000143:1
- 6,089 shares@ US$7.25Common StockSEC:0000886163-06-000143:2
- 6,089 shares@ US$10.76Common StockSEC:0000886163-06-000143:3
- 5,577 shares@ US$7.25Common StockSEC:0000886163-06-000143:4
- 5,577 shares@ US$10.76Common StockSEC:0000886163-06-000143:5
12 of 12 declarations
